CHANGJIANG PHARMACEUTICAL GROUP CO., LTD.

Highlights Changjiang Pharmaceutical Group Co., Ltd.

Equities

300391

CNE100001XN8

End-of-day quote Shenzhen S.E. Other stock markets 03:30:00 10/05/2024 am IST			5-day change	1st Jan Change
3.83 ^CNY	-9.24%		-5.43%	-50.52%

08/05	Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma	MT
29/04	Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	CI

Highlights

Unlock all the news on all businesses: Never miss an investment opportunity again!

100% Free Registration

Yichang HEC Still Negotiating Merger Deal with Sunshine Lake Pharma	08/05	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2024	29/04	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2023	29/04	CI
Yichang Hec Changjiang Pharmaceutical Updates on Possible Merger with Sunshine Lake Pharma	09/04	MT
Yichang Hec Changjiang Pharmaceutical's Net Profit Surges in 2023 as Revenue Jumps	01/04	MT
YiChang HEC ChangJiang Pharmaceutical's Profit Surges in 2023	29/03	MT
Yichang Hec Changjiang Pharmaceutical Expects Up to 2,627% Profit Surge in 2023	13/03	MT
HEC ChangJiang Pharmaceutical Increases Transaction Limits Under 2 Contracts	08/11	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Nine Months Ended September 30, 2023	24/23/24	CI
HEC ChangJiang Pharmaceutical's Insulin Injection Cleared for Market Launch in China	26/23/26	MT
HEC ChangJiang Pharmaceutical Returns to Profit on Surge in Anti-Viral Drug Sales	01/23/01	MT
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Half Year Ended June 30, 2023	22/23/22	CI
HEC ChangJiang Pharmaceutical Forecasts Surge in H1 Profit; Shares Rise 5%	27/23/27	MT
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd completed the acquisition of 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd.	25/23/25	CI
HEC ChangJiang Pharma Repurchases $400 Million Convertible Bonds Issued to Blackstone	06/23/06	MT
Yucong Tianshun No. 2 Private Equity Securities Investment Fund managed by Shanghai Yucong Asset Management Co., Ltd signed Share Transfer Agreement to acquire 5.9942% stake in Changjiang Pharmaceutical Group Co., Ltd. from Changxing Shengshi Fenghua Business Co., Ltd. for CNY 154.14 million.	15/23/15	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the Full Year Ended December 31, 2022	27/23/27	CI
Changjiang Pharmaceutical Group Co., Ltd. Reports Earnings Results for the First Quarter Ended March 31, 2023	27/23/27	CI
Changjiang Pharma Units Sign 359 Million Yuan Contracts	17/23/17	MT
YiChang HEC ChangJiang Pharma to Return to Profitability	20/23/20	MT

No results for this search

All News Analyst Reco. Highlights Insiders Transcripts Press Releases Official Publications Other languages Trading Ideas MarketScreener Editorial Features MarketScreener Strategies

Highlights Changjiang Pharmaceutical Group Co., Ltd.

Equities

300391

CNE100001XN8

Highlights

Filters